Biocurrent, Inc.

Biocurrent, Inc. is an early-stage bioelectronic medicine company with a clear path to sustainable revenue. The Company's research into non-invasive brain wave modulation led to the development of a non-invasive device, software application, and artificial intelligence engine capable of instantly modulating human brain waves. Their invention delivers dynamically generated, modulated electrical current varying in frequency, intensity, timing, and waveform. Artificial intelligence uses real-time brain wave spikes and discharges received wirelessly from an electroencephalogram (EEG) to optimize the current flow. Based on preclinical studies, the Company's technology may be effective at treating a wide range of neurological disorders and disabilities, including pain, addiction, and diabetic neuropathy. Their business model provides recurring revenue to both the Company and treatment providers. The Company is now seeking funding for commercialization. Founded in 2022 and headquartered in Mexico, Biocurrent, Inc. secured a significant $4.00M in Seed Round investment on 02 February 2022, led by Andrew Blount. With its innovative approach to bioelectronic medicine, Biocurrent, Inc. presents a compelling opportunity for investors looking to enter the healthcare industry.